ethyl phenylacetyl-Pro-Gly,
GVS 111,
GVS-111,
N-phenylacetyl-L-prolylglycine ethyl ester,
noopept,
Noopept,
157115-85-0,
GVS-111,
(S)-Ethyl 2-(1-(2-phenylacetyl)pyrrolidine-2-carboxamido)acetate,
Omberacetam,
UNII-4QBJ98683M,
GVS 111,
ethyl phenylacetyl-Pro-Gly,
Glycine, 1-(phenylacetyl)-L-prolyl-, ethyl ester,
n-phenylacetyl-l-prolylglycine ethyl ester,
4QBJ98683M,
ethyl 2-[[(2S)-1-(2-phenylacetyl)pyrrolidine-2-carbonyl]amino]acetate,
N-(1-(Phenylacetyl)-L-prolyl)glycine ethyl ester,
Glycine, N-(1-(phenylacetyl)-L-prolyl)-, ethyl ester,
ethyl 1-(phenylacetyl)-L-prolylglycinate,
N-[1-(Phenylacetyl)-L-prolyl]glycine Ethyl Ester,
Noopept;[(1-Phenylacetyl-pyrrolidine-2-carbonyl)-amino]-acetic acid ethyl ester,
AK122714,
SCHEMBL194807,
AC1L479U,
Noopept, >=98% (HPLC),
CTK4C9275,
AOB2286,
DTXSID80166214,
SYN5026,
ZINC3812682,
7870AA,
MFCD00941121,
AKOS016012268,
ACN-048214,
AM84514,
CS-1575,
KS-00000R58,
NCGC00378939-05,
AJ-45678,
AS-10555,
BC600710,
HY-17456,
LS-72814,
AX8246892,
FT-0687170,
N1120,
ST24036284,
Ethyl N-[1-(Phenylacetyl)-L-prolyl]glycinate,
115P850,
Glycine, 1-(2-phenylacetyl)-L-prolyl-, ethyl ester,
ethyl 2-{[(2S)-1-(2-phenylacetyl)pyrrolidin-2-yl]formamido}acetate,
Noopept?GVS-111?,
C17H22N2O4,
CID180496,
C17-H22-N2-O4,
Noopept, 99% - 100MG 100mg,
A15189,